Komori
Shin Nippon Biomedical Laboratories (2395) · RiskMitigated

Risks of Delayed DX Promotion and Shortages of DX Talent

First written in FY2023. 4 of 8 entries say "Mitigated", first in FY2024. Latest entry: FY2026.

8entries
4years
1from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2023 – FY2024-Q3MitigatedFY2024 – FY20262023: 320232024: 220242025: 120252026: 22026
Same theme, other companies
Difficulty Securing, Developing and Retaining Specialized and Highly Skilled IT PersonnelA theme 544 companies write about · 559 as a headwind · 4 as a tailwind

The whole theme swung hardest in 2026: 36 of 112 companies on the "Worse" side.

17 other companies' latest entry also says "Mitigated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 190 companies compared. The sentences above are computed from all 190.Comparing 200 of the theme's 563 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026MitigatedAnnual report

    「AIに専門性を持つチームを立上げ、併せてプロジェクトマネジメントスキルをもつ人材を主要プロジェクトに投入することで、DXプロジェクトの着実な遂行を行っています。」

    DX推進遅延・人材不足リスクに対し、AI専門チームの設置とプロジェクトマネジメント人材の投入を継続している。
  2. 2026-05-11MitigatedEarnings presentation

    「In the fiscal year ending March 2026, we introduced an automated cage-washing system. We also conducted a proof of concept for an AI-based system that automatically prepares final reports and began development toward full implementation in the fiscal year ending March 2027.」

    Implementation and development of automation and AI applications progressed, giving concrete shape to measures addressing delays in DX initiatives and personnel shortages.
  3. FY2026-H1MitigatedAnnual report

    「今期、最重要課題の一つとして財務経理処理のスピード化と正確性向上を実現するためにDX稼働を取り組んでいる」

    DX推進遅延・DX人材不足リスクへの対応として、財務経理処理のスピード化・正確性向上を目的とするDX稼働を進めている。
  4. FY2024MitigatedAnnual report

    「DX人財の育成に向けては、社内従業員を対象として、DX人材育成研修を実施しており、社内公募で募ったメンバーに対してe-learning形式のDX研修を実施しています。(※本研修の対象者は全社員)また、社内でDX推進プロジェクトを推進する際は、適宜、参画メンバーを幅広く社内公募で募って推進しています。加えて、AIに専門性を持つチームの立上げとDXプロジェクトの遂行を通じ、社内のDXに対する意識とナレッジを高めています。」

    DX遅延・DX人材不足リスクへの対策として、全社員対象の研修、社内公募、AI専門チーム、プロジェクト遂行を組み合わせた人材育成・実行体制を開示している。
  5. FY2024-Q3RestatedAnnual report

    「No new business or other risks arose during the nine-month period ended December 31, and there were no material changes to the business and other risks described in the annual securities report for the previous fiscal year.」

    DX推進遅延・DX人材不足リスクについて、重要な変更がないと記載している。
  6. FY2024-Q2RestatedAnnual report

    「No new business or other risks arose during the six months ended 30 September. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    DX推進遅延・DX人材不足リスクについて、重要な変更がないと記載している。
  7. FY2024-Q1RestatedAnnual report

    「No new business or other risks arose during the three months ended 30 June. There were also no material changes to the business and other risks described in the securities report for the previous fiscal year.」

    DX推進遅延・DX人材不足リスクについて、重要な変更がないと記載している。
  8. FY2023First statedAnnual report

    「①DXの取組みが進まず、競合劣後となるリスク ②DX人財の確保・育成が進まないリスク」

    DXの遅延やDX人材の確保・育成不足により、生産性・付加価値・市場競争力が低下するリスクを初めて独立して開示した。
Moved together

"Expanding Contracted Services through Strategic Alliances" moved the same way as this thread, in the same document, in 4 of its 8 moves.

444333★123456
  1. ★This thread
  2. 1Expanding Contracted Services through Strategic Alliances4×
  3. 2Focused Promotion of Growth Investment, DX and Human Capital4×
  4. 3Stable Supply of Laboratory Animals, Centered on Non-Human Primates4×
  5. 4A Global Value Chain Spanning Japan, the United States and Asia3×
  6. 5Securing and Developing Specialized Talent through SNBL Academy3×
  7. 6Commercializing the Nasal Delivery Platform Technology3×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
Shin Nippon Biomedical Laboratories's next results are scheduled for 2026-11-10. Read the earnings preview It last moved in the Earnings presentation of 2026-05-11: "Mitigated".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.